Päivi Pajukanta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Päivi Pajukanta has a total of 538 co-authors. Here are the top co-authors by number of shared publications:
Marcus Alvarez
Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, USA
25 shared publicationsMarkku Laakso
Institute of Clinical Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland
17 shared publicationsKirsi H. Pietiläinen
Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
15 shared publicationsJanet S. Sinsheimer
Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, USA
13 shared publications- Markku Laakso
Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland
13 shared publications - Kirsi Hannele Pietiläinen
Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
12 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (11) , 2772-2777
Genome-wide analyses identify 60 loci associated with liver triglyceride content
We performed a large-scale genome-wide association study meta-analysis of magnetic resonance imaging-derived liver triglyceride content across 71,488 European-ancestry participants from the UK Biobank, approximately doubling the sample size of previous genome-wide association studies 1 . We identified 60 independent loci, including 31 not previously reported, and estimated the single nucleotide polymorphism-based heritability of liver triglyceride content at 25%. Integrative fine-mapping and gene-prioritization analyses nominated candidate effector genes for 48 loci. Of the 31 newly identified variants, 14 were validated in meta-analyses of clinically diagnosed metabolic dysfunction-associated steatotic liver disease (42,163 cases and 1,646,254 controls). People in the highest versus lowest decile of a polygenic risk score for liver triglyceride content had 2.71-fold higher odds of cirrhosis and 7.47-fold higher odds of hepatocellular carcinoma. Plasma proteins associated with the liver triglyceride polygenic risk score were enriched for metabolic remodeling and inflammatory pathways, with liver-enriched protein signatures increasing and visceral adipose signatures decreasing with higher genetic risk. Together, these findings refine the genetic architecture of liver triglyceride content, linking polygenic susceptibility to downstream metabolic and inflammatory pathways and providing insights into the genetic basis of steatotic liver disease.
- 21 October 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (11) , 2772-2777
Open AccessGenome-wide analyses identify 60 loci associated with liver triglyceride content
We performed a large-scale genome-wide association study meta-analysis of magnetic resonance imaging-derived liver triglyceride content across 71,488 European-ancestry participants from the UK Biobank, approximately doubling the sample size of previous genome-wide association studies 1 . We identified 60 independent loci, including 31 not previously reported, and estimated the single nucleotide polymorphism-based heritability of liver triglyceride content at 25%. Integrative fine-mapping and gene-prioritization analyses nominated candidate effector genes for 48 loci. Of the 31 newly identified variants, 14 were validated in meta-analyses of clinically diagnosed metabolic dysfunction-associated steatotic liver disease (42,163 cases and 1,646,254 controls). People in the highest versus lowest decile of a polygenic risk score for liver triglyceride content had 2.71-fold higher odds of cirrhosis and 7.47-fold higher odds of hepatocellular carcinoma. Plasma proteins associated with the liver triglyceride polygenic risk score were enriched for metabolic remodeling and inflammatory pathways, with liver-enriched protein signatures increasing and visceral adipose signatures decreasing with higher genetic risk. Together, these findings refine the genetic architecture of liver triglyceride content, linking polygenic susceptibility to downstream metabolic and inflammatory pathways and providing insights into the genetic basis of steatotic liver disease.
- Open Access
- 9 October 2026
- Published by Springer Nature in Genome Medicine
Integration of single cell omics with biobank data discovers allele-specific trans effects of SREBF1 on adipocyte expression of nearly 100 genes
Background: Given the high global prevalence of obesity and lack of mechanistic, cell-type level knowledge of regulatory genes predisposing obesity, it would be critical to improve our understanding of how gene expression profiles are regulated in trans in adipocytes, the main cell-type in subcutaneous adipose tissue (SAT), and how that relates to obesity. Methods: We utilize single nucleus RNA-sequencing data sets from human SAT biopsies to elucidate the heritability of cardiometabolic disease risk in SAT cell-types and identify transcription factor (TF) encoding genes present in multiple functional pathways of the SAT cell-type marker genes. We integrate genome-wide association study (GWAS) data with expression quantitative trait locus (eQTL) data and conduct polygenic risk analyses for abdominal obesity and type 2 diabetes (T2D) to test if a cis regulatory GWAS variant for a key TF encoding gene, SREBF1 , harbors allele-specific trans effects on adipocyte marker genes and their polygenic risk. Results: We show that the heritability of epigenetic sites around SAT adipocyte marker genes is enriched for abdominal obesity, and that these cell-type markers are also enriched for central pathways of adipocyte function. Next, we discover SREBF1 as the most frequent TF in these adipocyte pathways and identify rs8079321, an abdominal obesity and T2D GWAS variant, regulating the bulk SAT SREBF1 expression in cis . We further discover and verify in an independent SAT snRNA-seq cohort, that the GWAS risk allele of rs8079321 affects the adipocyte expression of SREBF1 in cis and 89 SAT adipocyte marker genes in trans . Finally, we demonstrate that this trans effect extends to the polygenic risk by showing that the partitioned abdominal obesity and T2D polygenic risk scores of the 89 trans genes differ by the risk allele of rs8079321 in the UK Biobank, indicating widespread cell-type level cis -mediated trans effects on highly common CMDs. Conclusions: We discover that the SAT master TF, SREBF1, trans regulates the adipocyte expression profiles of nearly one hundred adipocyte marker genes in an allele-specific way, a finding that indicates that human trans -eQTL genes can be identified by integrating single cell omics with biobank data.
- 9 October 2026
- Published by Springer Nature in Genome Medicine
Open AccessIntegration of single cell omics with biobank data discovers allele-specific trans effects of SREBF1 on adipocyte expression of nearly 100 genes
Background: Given the high global prevalence of obesity and lack of mechanistic, cell-type level knowledge of regulatory genes predisposing obesity, it would be critical to improve our understanding of how gene expression profiles are regulated in trans in adipocytes, the main cell-type in subcutaneous adipose tissue (SAT), and how that relates to obesity. Methods: We utilize single nucleus RNA-sequencing data sets from human SAT biopsies to elucidate the heritability of cardiometabolic disease risk in SAT cell-types and identify transcription factor (TF) encoding genes present in multiple functional pathways of the SAT cell-type marker genes. We integrate genome-wide association study (GWAS) data with expression quantitative trait locus (eQTL) data and conduct polygenic risk analyses for abdominal obesity and type 2 diabetes (T2D) to test if a cis regulatory GWAS variant for a key TF encoding gene, SREBF1 , harbors allele-specific trans effects on adipocyte marker genes and their polygenic risk. Results: We show that the heritability of epigenetic sites around SAT adipocyte marker genes is enriched for abdominal obesity, and that these cell-type markers are also enriched for central pathways of adipocyte function. Next, we discover SREBF1 as the most frequent TF in these adipocyte pathways and identify rs8079321, an abdominal obesity and T2D GWAS variant, regulating the bulk SAT SREBF1 expression in cis . We further discover and verify in an independent SAT snRNA-seq cohort, that the GWAS risk allele of rs8079321 affects the adipocyte expression of SREBF1 in cis and 89 SAT adipocyte marker genes in trans . Finally, we demonstrate that this trans effect extends to the polygenic risk by showing that the partitioned abdominal obesity and T2D polygenic risk scores of the 89 trans genes differ by the risk allele of rs8079321 in the UK Biobank, indicating widespread cell-type level cis -mediated trans effects on highly common CMDs. Conclusions: We discover that the SAT master TF, SREBF1, trans regulates the adipocyte expression profiles of nearly one hundred adipocyte marker genes in an allele-specific way, a finding that indicates that human trans -eQTL genes can be identified by integrating single cell omics with biobank data.
- Open Access
- 3 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Decreased degree of adipocyte differentiation in visceral adipose tissue contributes to metabolic dysfunction-associated steatotic liver disease
The mechanisms connecting the human fat depots, subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT), to metabolic dysfunction-associated steatotic liver disease (MASLD) remain elusive. We hypothesize that in individuals with obesity, a decreased degree of adipocyte differentiation may contribute to ectopic fat accumulation in the liver, seen in MASLD. Here we show, using single nucleus RNA-sequencing from adipose tissue biopsies, that the predicted degree of VAT adipocyte differentiation is decreased in individuals with MASLD, with an attenuated impact observed in SAT adipocytes. Next, we discover that regional variants of the VAT adipocyte differentiation gene set explain a substantial proportion (17%) of MASLD heritability. These genes largely overlap (>50%) with adipocyte genes differentially expressed by MASLD, regulated by variants in cis . Finally, we show that these genes are linked to smaller adipocyte size. Together, our findings reveal that a decreased predicted degree of VAT adipocyte differentiation contributes to MASLD.
- 3 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessDecreased degree of adipocyte differentiation in visceral adipose tissue contributes to metabolic dysfunction-associated steatotic liver disease
The mechanisms connecting the human fat depots, subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT), to metabolic dysfunction-associated steatotic liver disease (MASLD) remain elusive. We hypothesize that in individuals with obesity, a decreased degree of adipocyte differentiation may contribute to ectopic fat accumulation in the liver, seen in MASLD. Here we show, using single nucleus RNA-sequencing from adipose tissue biopsies, that the predicted degree of VAT adipocyte differentiation is decreased in individuals with MASLD, with an attenuated impact observed in SAT adipocytes. Next, we discover that regional variants of the VAT adipocyte differentiation gene set explain a substantial proportion (17%) of MASLD heritability. These genes largely overlap (>50%) with adipocyte genes differentially expressed by MASLD, regulated by variants in cis . Finally, we show that these genes are linked to smaller adipocyte size. Together, our findings reveal that a decreased predicted degree of VAT adipocyte differentiation contributes to MASLD.
- Open Access
- 20 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Adipose single cell epigenome and transcriptome localize genetic risk for cardiometabolic disease and accelerated aging
Obesity impairs subcutaneous adipose tissue function, which predisposes to chronic cardiometabolic comorbidities and accelerated biological aging. However, regulatory variants, their target genes and epigenomic landscape underlying this predisposition in each subcutaneous adipose tissue cell-type remain elusive. Our subcutaneous adipose tissue cell-type level cis -expression quantitative trait and colocalization analyses reveal ci s-expression quantitative trait locus variants, regulating 279 genes for 33 cardiometabolic disease and aging traits. Most of these genes are cell-type-specific (90%), led by adipocytes (55%), and missed in previous bulk tissue colocalization studies. Conducting subcutaneous adipose tissue cell-type level epigenome analysis, we discover that the vast majority (81%) of these colocalized cardiometabolic disease and aging risk variants map to the active chromatin compartments that comprise only 45% of the human genome, revealing three-dimensional epigenome in the center of cardiometabolic disease and aging risk. These findings uncover genetic and epigenomic regulation of genes underlying 33 cardiometabolic disease and aging traits in subcutaneous adipose tissue cell-types and offer critical insights into the principal role of three-dimensional chromatin in disease risk.
- 20 April 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessAdipose single cell epigenome and transcriptome localize genetic risk for cardiometabolic disease and accelerated aging
Obesity impairs subcutaneous adipose tissue function, which predisposes to chronic cardiometabolic comorbidities and accelerated biological aging. However, regulatory variants, their target genes and epigenomic landscape underlying this predisposition in each subcutaneous adipose tissue cell-type remain elusive. Our subcutaneous adipose tissue cell-type level cis -expression quantitative trait and colocalization analyses reveal ci s-expression quantitative trait locus variants, regulating 279 genes for 33 cardiometabolic disease and aging traits. Most of these genes are cell-type-specific (90%), led by adipocytes (55%), and missed in previous bulk tissue colocalization studies. Conducting subcutaneous adipose tissue cell-type level epigenome analysis, we discover that the vast majority (81%) of these colocalized cardiometabolic disease and aging risk variants map to the active chromatin compartments that comprise only 45% of the human genome, revealing three-dimensional epigenome in the center of cardiometabolic disease and aging risk. These findings uncover genetic and epigenomic regulation of genes underlying 33 cardiometabolic disease and aging traits in subcutaneous adipose tissue cell-types and offer critical insights into the principal role of three-dimensional chromatin in disease risk.
- Open Access
- 28 March 2026
- Published by Springer Nature in Genome Medicine
- Vol. 18 (1)
Lessons from single cell omics: admixed American ancestry and sex confer cardiometabolic disease risk in Mexicans
Background: Subcutaneous adipose tissue (SAT), the key human fat depot for cardiometabolic health, exhibits high cellular heterogeneity. However, the contributions of contexts and cardiometabolic diseases (CMDs) to this heterogeneity are poorly understood, especially in admixed populations. Despite the substantially increased risk of obesity and obesity-related CMDs in Mexicans, cell-type-level mechanisms behind their elevated CMD risk have remained elusive. Methods: To investigate how cell-type and subcell-type level profiles of SAT are impacted by sex, admixed American ancestry, CMD traits, and cell-type level cis regulation in Mexicans, we generated a Mexican SAT single nucleus RNA sequencing cohort ( n = 49). We performed cell-type level differential expression testing, weighted gene co-expression analysis, and c is -expression quantitative trait locus (eQTL) mappings. We then integrated genome-wide association study (GWAS) and Mexican population level data to assess partitioned polygenic risk for lipid outcomes and colocalization between SAT cell-type level cis -eQTL variants and lipid GWAS variants. Results: First, we discovered and validated a sex-associated adipocyte subtype, overlapping an adipocyte co-expression network with 132 adipocyte function centered genes, including key triglyceride biosynthesis genes, GPAM , DGAT2 , ACSL1 , and LPL , that are differentially expressed (DE) by sex. The cis regional variants of these network genes DE by sex confer a significant sex-specific polygenic risk to serum triglycerides, a clinically important atherogenic lipid trait. We also found significant enrichment of progesterone receptor binding at these variant sites, contributing to the sex-specific findings. Second, we identified 34 colocalized genes for three lipid traits, of which 25 (74%) genes have not been identified in previous European colocalization studies using SAT bulk tissue. Among the discovered 25 lipid GWAS genes, 12 are regulated by Mexican enriched and seven by European enriched cis -eQTL variants, thus mechanistically elucidating the genetic dyslipidemia susceptibility at the cell-type level in both Europeans and Mexicans. The identified 12 lipid GWAS genes regulated by a Mexican enriched variant include an important adipogenesis gene, CYP26B1 , and a regulator of adipocyte browning and beiging, GPR180 . Conclusions: We identify sex- and ancestry-stratified genes and variants contributing to the risk of adverse cardiometabolic outcomes and improve understanding of the complex cell-type level biological mechanisms underlying CMDs in Mexicans.
- 28 March 2026
- Published by Springer Nature in Genome Medicine
- Vol. 18 (1)
Open AccessLessons from single cell omics: admixed American ancestry and sex confer cardiometabolic disease risk in Mexicans
Background: Subcutaneous adipose tissue (SAT), the key human fat depot for cardiometabolic health, exhibits high cellular heterogeneity. However, the contributions of contexts and cardiometabolic diseases (CMDs) to this heterogeneity are poorly understood, especially in admixed populations. Despite the substantially increased risk of obesity and obesity-related CMDs in Mexicans, cell-type-level mechanisms behind their elevated CMD risk have remained elusive. Methods: To investigate how cell-type and subcell-type level profiles of SAT are impacted by sex, admixed American ancestry, CMD traits, and cell-type level cis regulation in Mexicans, we generated a Mexican SAT single nucleus RNA sequencing cohort ( n = 49). We performed cell-type level differential expression testing, weighted gene co-expression analysis, and c is -expression quantitative trait locus (eQTL) mappings. We then integrated genome-wide association study (GWAS) and Mexican population level data to assess partitioned polygenic risk for lipid outcomes and colocalization between SAT cell-type level cis -eQTL variants and lipid GWAS variants. Results: First, we discovered and validated a sex-associated adipocyte subtype, overlapping an adipocyte co-expression network with 132 adipocyte function centered genes, including key triglyceride biosynthesis genes, GPAM , DGAT2 , ACSL1 , and LPL , that are differentially expressed (DE) by sex. The cis regional variants of these network genes DE by sex confer a significant sex-specific polygenic risk to serum triglycerides, a clinically important atherogenic lipid trait. We also found significant enrichment of progesterone receptor binding at these variant sites, contributing to the sex-specific findings. Second, we identified 34 colocalized genes for three lipid traits, of which 25 (74%) genes have not been identified in previous European colocalization studies using SAT bulk tissue. Among the discovered 25 lipid GWAS genes, 12 are regulated by Mexican enriched and seven by European enriched cis -eQTL variants, thus mechanistically elucidating the genetic dyslipidemia susceptibility at the cell-type level in both Europeans and Mexicans. The identified 12 lipid GWAS genes regulated by a Mexican enriched variant include an important adipogenesis gene, CYP26B1 , and a regulator of adipocyte browning and beiging, GPR180 . Conclusions: We identify sex- and ancestry-stratified genes and variants contributing to the risk of adverse cardiometabolic outcomes and improve understanding of the complex cell-type level biological mechanisms underlying CMDs in Mexicans.
- Open Access
- 9 December 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (12) , 3175-3184
A biobank-scale test of marginal epistasis reveals genome-wide signals of polygenic interaction effects
The contribution of genetic interactions (epistasis) to human complex trait variation remains poorly understood due, in part, to the statistical and computational challenges involved in testing for interaction effects. Here we introduce FAME (FAst Marginal Epistasis test), a method that can test for marginal epistasis of a single-nucleotide polymorphism (SNP) on a quantitative trait (whether the effect of an SNP on the trait is modulated by genetic background). FAME is computationally efficient, enabling tests of marginal epistasis on biobank-scale data. Applying FAME to genome-wide association study (GWAS)-significant trait-SNP associations across 53 quantitative traits and ≈300 000 unrelated White British individuals in the UK Biobank (UKBB), we identified 16 significant marginal epistasis signals across 12 traits ( $$P < \frac{5\times {10}^{-8}}{53}$$ ). Leveraging the scalability of FAME, we further localized marginal epistasis signals across chromosomes and estimated the proportion of variance explained by marginal epistasis effects. Our study provides evidence for interactions between individual genetic variants and polygenic background influencing complex traits.- 9 December 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (12) , 3175-3184
Open AccessA biobank-scale test of marginal epistasis reveals genome-wide signals of polygenic interaction effects
The contribution of genetic interactions (epistasis) to human complex trait variation remains poorly understood due, in part, to the statistical and computational challenges involved in testing for interaction effects. Here we introduce FAME (FAst Marginal Epistasis test), a method that can test for marginal epistasis of a single-nucleotide polymorphism (SNP) on a quantitative trait (whether the effect of an SNP on the trait is modulated by genetic background). FAME is computationally efficient, enabling tests of marginal epistasis on biobank-scale data. Applying FAME to genome-wide association study (GWAS)-significant trait-SNP associations across 53 quantitative traits and ≈300 000 unrelated White British individuals in the UK Biobank (UKBB), we identified 16 significant marginal epistasis signals across 12 traits ( $$P < \frac{5\times {10}^{-8}}{53}$$ ). Leveraging the scalability of FAME, we further localized marginal epistasis signals across chromosomes and estimated the proportion of variance explained by marginal epistasis effects. Our study provides evidence for interactions between individual genetic variants and polygenic background influencing complex traits. - Open Access
Comprehensive gene heritability estimation reveals the genetic architecture of rare coding variants underlying complex traits
Whole-exome sequencing (WES) enables high-resolution interrogation of the contribution of rare coding variants to complex trait variation. However, existing methods for heritability estimation attributed to rare-coding variants are often limited by the effects of linkage disequilibrium (LD) and by the sparse nature of rare variant data. We introduce FLEX (Fast, LD-aware Estimation of eXome-wide and gene-level heritability), a scalable and flexible framework for estimating and partitioning heritability across genes or sets of genes using WES data. FLEX integrates all coding variants—from common to ultra-rare—within a unified model and corrects for LD-induced effects to improve the accuracy of heritability estimates. In addition, FLEX supports both individual-level and summary statistic data and is computationally efficient for biobank-scale datasets. Through extensive simulations, we show that FLEX is well-calibrated while providing accurate heritability estimates. We applied FLEX to WES data across N = 153, 351 unrelated European ancestry individuals and 20 quantitative traits in the UK Biobank. We identified 64 gene-trait pairs with significant gene-level heritability (p < 0.05/18, 624 accounting for the number of protein-coding genes tested), among which rare coding variants explained 38% of gene-level heritability, on average. Compared to heritability estimates from genome-wide imputed SNPs, incorporation of rare and ultra-rare coding variants led to a 24.8% increase in heritability on average, while effect sizes at rare and ultra-rare variants are substantially larger (≈18x on average). Partitioning across variant effect annotations, we find that predicted loss-of-function variants had stronger individual effects than missense variants (24% on average) while missense variants accounted for a greater share of rare coding heritability. Together, FLEX provides an adaptable and accurate approach for quantifying gene-level heritability, advancing our understanding of the genetic architecture of complex traits, and facilitating the discovery of trait-relevant genes.
Open AccessComprehensive gene heritability estimation reveals the genetic architecture of rare coding variants underlying complex traits
Whole-exome sequencing (WES) enables high-resolution interrogation of the contribution of rare coding variants to complex trait variation. However, existing methods for heritability estimation attributed to rare-coding variants are often limited by the effects of linkage disequilibrium (LD) and by the sparse nature of rare variant data. We introduce FLEX (Fast, LD-aware Estimation of eXome-wide and gene-level heritability), a scalable and flexible framework for estimating and partitioning heritability across genes or sets of genes using WES data. FLEX integrates all coding variants—from common to ultra-rare—within a unified model and corrects for LD-induced effects to improve the accuracy of heritability estimates. In addition, FLEX supports both individual-level and summary statistic data and is computationally efficient for biobank-scale datasets. Through extensive simulations, we show that FLEX is well-calibrated while providing accurate heritability estimates. We applied FLEX to WES data across N = 153, 351 unrelated European ancestry individuals and 20 quantitative traits in the UK Biobank. We identified 64 gene-trait pairs with significant gene-level heritability (p < 0.05/18, 624 accounting for the number of protein-coding genes tested), among which rare coding variants explained 38% of gene-level heritability, on average. Compared to heritability estimates from genome-wide imputed SNPs, incorporation of rare and ultra-rare coding variants led to a 24.8% increase in heritability on average, while effect sizes at rare and ultra-rare variants are substantially larger (≈18x on average). Partitioning across variant effect annotations, we find that predicted loss-of-function variants had stronger individual effects than missense variants (24% on average) while missense variants accounted for a greater share of rare coding heritability. Together, FLEX provides an adaptable and accurate approach for quantifying gene-level heritability, advancing our understanding of the genetic architecture of complex traits, and facilitating the discovery of trait-relevant genes.
- Open Access
Integrated ambient modeling and genetic demultiplexing of single-cell RNA+ATAC multiome experiments with Ambimux
Single cell technologies have advanced at a rapid pace, providing assays for various molecular phenotypes. Droplet-based single cell technologies, particularly those based on nuclei isolation, such as simultaneous RNA+ATAC single-cell multiome, are susceptible to exogenous ambient molecule contamination, which can increase noise in cell type-level associations. We reasoned that genotype-based sample multiplexing can provide an opportunity to infer this ambient contamination by leveraging DNA variation in sequenced reads. Thus, we developed ambimux, a likelihood-based method to estimate ambient fractions and demultiplex single-cell multiome experiments using genotype-level data. Ambimux models the ambient or nuclear probability at the read level and thus can classify empty droplets and estimate droplet-specific ambient molecule fractions in each modality. We first evaluated our method using simulated data sets across a range of parameters. We found that ambimux closely estimated the ground truth droplet contamination fractions in the RNA (MAE=0.048) and ATAC (MAE=0.042) modalities. As a result, ambimux maintained high specificity (>95%) and was able to correctly assign singlets at considerably high ambient fractions (up to 60%) for both RNA and ATAC modalities. In comparison with models that do not consider ambient contamination, these only maintained similar sensitivity levels at considerably lower ambient fractions (up to 25%). We then generated a real data set of seven visceral adipose tissue biopsies run on a single 10x Multiome channel. We ran ambimux and detected 4,986 singlets, capturing similar numbers as other methods. Then, we sought to evaluate the fidelity of the ambient fraction estimates from ambimux. We split singlets into ambient-enriched (>5% contamination in both modalities) or nuclear-enriched (<5% in both) droplets and performed gene-peak linkage analysis. Low ambient droplets resulted in more significant hits with gene-peak links enriched at the transcription start site relative to high ambient droplets, suggesting that the ambient droplets identified by ambimux hamper the identification of biologically meaningful signals. In summary, we developed a joint single-cell multiome demultiplexing method, ambimux, that accurately models and estimates ambient molecule contamination in each modality.
Open AccessIntegrated ambient modeling and genetic demultiplexing of single-cell RNA+ATAC multiome experiments with Ambimux
Single cell technologies have advanced at a rapid pace, providing assays for various molecular phenotypes. Droplet-based single cell technologies, particularly those based on nuclei isolation, such as simultaneous RNA+ATAC single-cell multiome, are susceptible to exogenous ambient molecule contamination, which can increase noise in cell type-level associations. We reasoned that genotype-based sample multiplexing can provide an opportunity to infer this ambient contamination by leveraging DNA variation in sequenced reads. Thus, we developed ambimux, a likelihood-based method to estimate ambient fractions and demultiplex single-cell multiome experiments using genotype-level data. Ambimux models the ambient or nuclear probability at the read level and thus can classify empty droplets and estimate droplet-specific ambient molecule fractions in each modality. We first evaluated our method using simulated data sets across a range of parameters. We found that ambimux closely estimated the ground truth droplet contamination fractions in the RNA (MAE=0.048) and ATAC (MAE=0.042) modalities. As a result, ambimux maintained high specificity (>95%) and was able to correctly assign singlets at considerably high ambient fractions (up to 60%) for both RNA and ATAC modalities. In comparison with models that do not consider ambient contamination, these only maintained similar sensitivity levels at considerably lower ambient fractions (up to 25%). We then generated a real data set of seven visceral adipose tissue biopsies run on a single 10x Multiome channel. We ran ambimux and detected 4,986 singlets, capturing similar numbers as other methods. Then, we sought to evaluate the fidelity of the ambient fraction estimates from ambimux. We split singlets into ambient-enriched (>5% contamination in both modalities) or nuclear-enriched (<5% in both) droplets and performed gene-peak linkage analysis. Low ambient droplets resulted in more significant hits with gene-peak links enriched at the transcription start site relative to high ambient droplets, suggesting that the ambient droplets identified by ambimux hamper the identification of biologically meaningful signals. In summary, we developed a joint single-cell multiome demultiplexing method, ambimux, that accurately models and estimates ambient molecule contamination in each modality.
- Open Access
- 20 August 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (9) , 2238-2249
Single-cell DNA methylome and 3D genome atlas of human subcutaneous adipose tissue
The cell-type-level epigenomic landscape of human subcutaneous adipose tissue (SAT) is not well characterized. Here, we elucidate the epigenomic landscape across SAT cell types using snm3C-seq. We find that SAT CG methylation (mCG) displays pronounced hypermethylation in myeloid cells and hypomethylation in adipocytes and adipose stem and progenitor cells, driving nearly half of the 705,063 differentially methylated regions (DMRs). Moreover, TET1 and DNMT3A are identified as plausible regulators of the cell-type-level mCG profiles. Both global mCG profiles and chromosomal compartmentalization reflect SAT cell-type lineage. Notably, adipocytes display more short-range chromosomal interactions, forming complex local 3D genomic structures that regulate transcriptional functions, including adipogenesis. Furthermore, adipocyte DMRs and A compartments are enriched for abdominal obesity genome-wide association study (GWAS) variants and polygenic risk, while myeloid A compartments are enriched for inflammation. Together, we characterize the SAT single-cell-level epigenomic landscape and link GWAS variants and partitioned polygenic risk of abdominal obesity and inflammation to the SAT epigenome.
- 20 August 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (9) , 2238-2249
Open AccessSingle-cell DNA methylome and 3D genome atlas of human subcutaneous adipose tissue
The cell-type-level epigenomic landscape of human subcutaneous adipose tissue (SAT) is not well characterized. Here, we elucidate the epigenomic landscape across SAT cell types using snm3C-seq. We find that SAT CG methylation (mCG) displays pronounced hypermethylation in myeloid cells and hypomethylation in adipocytes and adipose stem and progenitor cells, driving nearly half of the 705,063 differentially methylated regions (DMRs). Moreover, TET1 and DNMT3A are identified as plausible regulators of the cell-type-level mCG profiles. Both global mCG profiles and chromosomal compartmentalization reflect SAT cell-type lineage. Notably, adipocytes display more short-range chromosomal interactions, forming complex local 3D genomic structures that regulate transcriptional functions, including adipogenesis. Furthermore, adipocyte DMRs and A compartments are enriched for abdominal obesity genome-wide association study (GWAS) variants and polygenic risk, while myeloid A compartments are enriched for inflammation. Together, we characterize the SAT single-cell-level epigenomic landscape and link GWAS variants and partitioned polygenic risk of abdominal obesity and inflammation to the SAT epigenome.
- Open Access
Longitudinal adipose tissue single cell transcriptomics reveals genes and variants regulating weight loss after bariatric surgery
Ability to lose weight during different obesity treatments shows substantial variability between individuals and is likely under genetic control; however, the underlying predictive variants and weight loss genes remain unknown. Here we profiled longitudinal, single cell level adipose transcriptomes of individuals undergoing bariatric surgery to elucidate genes and their regulatory variants contributing to interindividual variability in weight loss outcomes. We identified wide-spread cellular and subcellular transcriptional changes to weight loss with most profound responses in adipocyte subtypes. By clustering the weight loss genes based on their cell-type level co-expression profiles, we uncovered functionally distinct subsets of genes reflecting altered adipocyte expression of central adipocyte function enriched genes. Next, we discovered that body mass index (BMI) polygenic risk score (PRS) built using the cis regulatory variants in these 45 adipocyte weight loss genes significantly predict the magnitude of the achieved weight loss and are strongly enriched for variance explained in the change of BMI. Taken together, this longitudinal single nucleus adipose data establishes gene signatures for weight loss and discovers genetic regulators underlying the interindividual variability of weight loss.
Open AccessLongitudinal adipose tissue single cell transcriptomics reveals genes and variants regulating weight loss after bariatric surgery
Ability to lose weight during different obesity treatments shows substantial variability between individuals and is likely under genetic control; however, the underlying predictive variants and weight loss genes remain unknown. Here we profiled longitudinal, single cell level adipose transcriptomes of individuals undergoing bariatric surgery to elucidate genes and their regulatory variants contributing to interindividual variability in weight loss outcomes. We identified wide-spread cellular and subcellular transcriptional changes to weight loss with most profound responses in adipocyte subtypes. By clustering the weight loss genes based on their cell-type level co-expression profiles, we uncovered functionally distinct subsets of genes reflecting altered adipocyte expression of central adipocyte function enriched genes. Next, we discovered that body mass index (BMI) polygenic risk score (PRS) built using the cis regulatory variants in these 45 adipocyte weight loss genes significantly predict the magnitude of the achieved weight loss and are strongly enriched for variance explained in the change of BMI. Taken together, this longitudinal single nucleus adipose data establishes gene signatures for weight loss and discovers genetic regulators underlying the interindividual variability of weight loss.